IHI - iShares U.S. Medical Devices ETF

NYSEArca - NYSEArca Delayed Price. Currency in USD
273.46
+0.79 (+0.29%)
At close: 4:00PM EST
Stock chart is not supported by your current browser
Previous Close272.67
Open273.19
Bid273.77 x 1000
Ask273.87 x 900
Day's Range272.67 - 274.24
52 Week Range206.47 - 274.24
Volume120,982
Avg. Volume187,717
Net Assets4.84B
NAV272.62
PE Ratio (TTM)N/A
Yield0.33%
YTD Daily Total Return3.18%
Beta (5Y Monthly)0.95
Expense Ratio (net)0.43%
Inception Date2006-05-01
  • 6 Sector ETFs & Stocks to Watch on December U.S. Inflation
    Zacks

    6 Sector ETFs & Stocks to Watch on December U.S. Inflation

    These sector ETFs and stocks should benefit from decent price gains in the month of December.

  • ETF Trends

    A Look at the S&P Sectors from 2019

    The S&P 500 continues its run in Market State 1, now at 14 consecutive days. Typically, it is a good sign to see the Nasdaq leading the S&P 500. When analyzing the market, and more specifically the S&P 500, it is always interesting to look at the strength of certain market sectors.

  • Top Performing ETFs of the Decade
    Zacks

    Top Performing ETFs of the Decade

    We take a look at the best performing areas of the decade

  • Spending deal to repeal certain ‘Obamacare’ taxes, lift tobacco-buying age to 21
    MarketWatch

    Spending deal to repeal certain ‘Obamacare’ taxes, lift tobacco-buying age to 21

    Retired coal miners and longtime opponents of Obama-era taxes on high-cost health plans are eyeing big wins as top congressional leaders and the Trump White House close in on a deal on a government-wide spending bill.

  • 5 ETFs & Stocks to Profit From One-Year High U.S. Inflation
    Zacks

    5 ETFs & Stocks to Profit From One-Year High U.S. Inflation

    The annual U.S. inflation for the month of November beat expectations and put these ETFs and stocks in focus.

  • Had enough of ‘OK, boomer’? Not if you want to make money with these stocks
    MarketWatch

    Had enough of ‘OK, boomer’? Not if you want to make money with these stocks

    Internet memes can be funny — and annoying — but they can also remind us of lucrative investment opportunities from time to time. A current trend is for young adults to make fun of baby boomers for being clueless. Baby boomers were born during the postwar economic expansion from 1946 through 1964.

  • Investopedia

    Healthy Bounce

    Finance and health care took the lead as stocks rebound. What are the best industry groups in the surprisingly robust health care sector?

  • 5 ETFs to Ride on Highest Core U.S. Inflation Rate in a Year
    Zacks

    5 ETFs to Ride on Highest Core U.S. Inflation Rate in a Year

    The core inflation rate for August hits the highest level in a year while the overall annual consumer price inflation declines. These ETFs could be beneficiary of this trend.

  • ETF Trends

    Healthcare ETF is Getting Frothy

    Up nearly 24% year-to-date, the iShares US Medical Devices ETF (IHI) , the largest ETF dedicated to medical device manufacturers, is continuing its run of being on the of the best-performing healthcare ETFs over the past several years. Industry observers argue that medical technology companies can tap into increased healthcare spending among emerging economies while the U.S. market has matured and could experience slower growth. Healthcare is typically less correlated to the general economy and has, and will likely continue to, see high top-line growth due to the aging U.S population,” according to Seeking Alpha.

  • IShares ETF Owns Some Of Today's Best Medical Stocks
    Investor's Business Daily

    IShares ETF Owns Some Of Today's Best Medical Stocks

    A wobbly stock market has knocked many ETFs off their highs, but iShares U.S. Medical Devices is holding near a prior high. Now the fund, boasting some of the best health care stocks, is in a buy area.

  • ETF Trends

    A Surprise Healthcare ETF Could be Pinched by Trade Wars

    The healthcare sector is usually viewed as defensive and derives significant portions of revenue from within the U.S., making the group an ideal sector for investors looking to avoid the trade war controversy. The previously high-flying iShares US Medical Devices ETF (IHI) , the largest ETF dedicated to medical device manufacturers, is up 10.42% year-to-date, but some market observers see the fund's components as potentially vulnerable to a trade spat with Mexico, the largest trading partner of the U.S. “For the overall medtech space, I think it’s going to be manageable,” RBC Capital Markets analyst Brandon Henry told Barron’s on Friday morning.

  • Dow Jones Today: A Miserable May Ends in Miserable Fashion
    InvestorPlace

    Dow Jones Today: A Miserable May Ends in Miserable Fashion

    With the benefit of hindsight, the old adage about selling in May and going away proved to be good advice this year. As has been the case for much of this month, trade wars sank stocks on Friday as the Nasdaq Composite and the S&P 500 slipped by 1.5% and 1.3% while the Dow Jones Industrial Average dropped 1.4% today.Source: Shutterstock Chinese retaliatory tariffs on over 5,100 U.S.-made products go into effect June 1. Beijing boosted tariffs on the U.S. imports to 20% to 25% from a previous range of 5% to 10%. However, those were not the tariffs that really roiled markets on Friday.The White House announced tariffs on Mexican imports to the U.S., slated to start at 5% on June 10 and rising to 25% until Mexico steps up to help the U.S. with the illegal immigration issue.InvestorPlace - Stock Market News, Stock Advice & Trading Tips"Washington will impose a 5% tariff from June 10, which would then rise steadily to 25% until illegal immigration across the southern border was stopped, President Donald Trump tweeted late on Thursday," reports Reuters. A Sea Of Red in the MarketsAt the close on Friday, all of the members of the Dow Jones Industrial Average were trading lower, making it easy to find offenders for May's final trading session. While some Dow Jones components were bigger losers on the day, Exxon Mobil (NYSEARCA:XOM) and Chevron (NYSE:CVX) each lost more than 1% as oil prices dropped. * 7 Stocks to Buy for Monster Growth Adding to the woes for the two largest U.S. oil companies are the aforementioned Mexico tariffs. Tariffs on Mexican oil could be a negative for U.S. refiners. As integrated oil giants, Exxon and Chevron have major refining operations."Mexico sends 600K-700K bbl/day of oil to the U.S., mostly to refiners that process the crude into gasoline, diesel and other products, while Mexico buys more than 1M bbl/day of U.S. crude and fuel, more than any other country," according to Seeking Alpha.As was noted here yesterday, Verizon Communications (NYSE:VZ) was slammed Thursday after UBS lowered its rating on the stock to "neutral" from "buy." That now looks like a prescient call because shares of Verizon and rival AT&T (NYSE:T) were drubbed Friday on reports that Amazon (NASDAQ:AMZN) could be looking to enter the wireless telecommunications business.Another potential area of concern amid the Mexico tariffs is medical device makers. While no Dow component is a dedicated medical device manufacturer, Johnson & Johnson (NYSE:JNJ) has a big footprint in this space.That industry "relies on Mexico for 15% of its imports and 7% of its exports," according to Barron's. The iShares U.S. Medical Devices ETF (NYSEARCA:IHI) traded lower today. Bottom Line on the Dow Jones TodayThe Dow Jones Industrial Average lost more than 5% this month, so the bottom line is May was a brutal month and investors are right to be glad it is in the books. However, if seasonal trends hold true to form, there could be June gloom.Over the past 20 years, the S&P 500 has averaged a June decline of 0.7%, making the sixth month of the year the second-worst month in which to be long stocks.In terms of sectors that historically perform well in June, it is, not surprisingly, defensive fare. Utilities and healthcare are usually the best-performing groups in the S&P 500 in June. Those are the only two sectors that average positive returns in the sixth month of the year.As of this writing, Todd Shriber does not own any of the aforementioned securities. More From InvestorPlace * 4 Top American Penny Pot Stocks (Buy Before June 21) * 7 Stocks to Buy for Monster Growth * Ranking the Top 10 Stock Buybacks of Last Year * 5 Stocks Under $10 With Big Upside Potential Compare Brokers The post Dow Jones Today: A Miserable May Ends in Miserable Fashion appeared first on InvestorPlace.

  • Healthcare's Near-Term Prospects Bright: 3 ETFs in Focus
    Zacks

    Healthcare's Near-Term Prospects Bright: 3 ETFs in Focus

    The healthcare space might have seen a sluggish year so far. But its valuation and near-term prospects make it a good space for investments right now.

  • Best ETFs: Innovation Shines In iShares Devices Fund
    Investor's Business Daily

    Best ETFs: Innovation Shines In iShares Devices Fund

    While biotechs and pharmaceuticals are making breakthrough discoveries, makers of medical devices are innovating too, one reason iShares U.S. Medical Devices is now one of the best ETFs.

  • 10 Top-Ranked ETFs Leading the 10-Year Bull Run
    Zacks

    10 Top-Ranked ETFs Leading the 10-Year Bull Run

    We have presented a bunch of top-performing ETFs of the 10-year bull market that will continue to outperform in the coming months given that these have a Zacks ETF Rank 1 (Strong Buy) or 2 (Buy).

  • ETF Trends

    Healthcare ETF Keeps Hitting New Highs

    Just a dozen ETFs hit record highs on Friday. Extending its 2019 gains to 15%, the iShares US Medical Devices ETF (NYSEArca: IHI) was one of the ETFs hitting all-times on Friday. That as the broader healthcare ...

  • One Year of Trade Spat: 5 ETF Winners
    Zacks

    One Year of Trade Spat: 5 ETF Winners

    Trump tariffs turned one-year old in March, causing upheaval in the global markets. But these ETFs still succeeded.

  • Analysts Are Optimistic ahead of Boston Scientific’s Q4 Results
    Market Realist

    Analysts Are Optimistic ahead of Boston Scientific’s Q4 Results

    Analysts Are Optimistic ahead of Boston Scientific's Q4 ResultsAnalysts’ recommendations and target priceBoston Scientific (BSX) is scheduled to post its fourth-quarter and 2018 earnings results on February 6, 2019. In this article, we’ll

  • ETF Trends

    Healthcare ETFs Slip After Abbot Lab’s Revenue Miss, Weak Outlook

    Healthcare ETFs weakened Wednesday after Abbot Laboratories (ABT) slipped on a revenue miss and revealed an uninspiring forecast for the first quarter of the new year. The Health Care Select Sector SPDR ETF (XLV) fell 0.3% on Wednesday while the S&P 500 was 0.1% lower. Abbot Laboratories' quarterly revenue fell short of expectations due to lower sales of generic drugs in the emerging markets, Reuters reports.